Twice weekly intake of farmed Atlantic salmon (Salmo salar) positively influences lipoprotein concentration and particle size in overweight men and women

Nutrition Research

Volumn 36, Issue 9, 2016, Pages 899-906

  Raatz, Susan K ^a,b   Johnson, LuAnn K ^a   Rosenberger, Thad A ^c   Picklo, Matthew J ^a,d  

^a GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d UNIVERSITY OF NORTH DAKOTA   (United States)

Author keywords

HDL; LDL; Lipids; Lipoprotein particle; Lipoproteins; Salmon; VLDL

Indexed keywords

ARACHIDONIC ACID; CHYLOMICRON; DOCOSAHEXAENOIC ACID; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PALMITIC ACID; STEARIC ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET THERAPY; FEMALE; FOOD INTAKE; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PARTICLE SIZE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SALMO SALAR; THERAPY EFFECT; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; BODY MASS; DIET; FEEDING BEHAVIOR; SEA FOOD;

ANIMALS; BODY MASS INDEX; CHYLOMICRONS; DIET; FATTY ACIDS, OMEGA-3; FEEDING BEHAVIOR; HUMANS; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MIDDLE AGED; OBESITY; OVERWEIGHT; PARTICLE SIZE; SALMO SALAR; SEAFOOD; TRIGLYCERIDES;

EID: 84981742578     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2016.06.011     Document Type: Article

References (47)

1. [1] Goff, DC, Lloyd-Jones, DM, Bennett, G, O'Donnell, C, Coady, S, Robinson, J, 2013 ACC/AHA guideline on the assessment of cardiovascular risk. J Am Coll Cardiol 129 (2014), S49–S73.
2. [2] Bansal, S, Buring, JE, Rifai, N, Mora, S, Sacks, FM, Ridker, P, Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 298 (2007), 309–316.
3. [3] Kelishadi, R, Poursafa, P, A review on the genetic, environmental, and lifestyle aspects of the early-life origins of cardiovascular disease. Curr Prob Pediatr Adoles Health Care 44 (2014), 54–72.
4. [4] Rosenson, RS, Davidson, MH, Hirsh, BJ, Kathiresan, S, Gaudet, D, Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease. J Am Coll Cardiol 64 (2014), 2525–2540.
5. [5] Stampfer, MJ, Hu, FB, Manson, JE, Rimm, EB, Willett, WC, Primary prevention of coronary heart disease in women through diet and lifestyle. NEJM 343 (2000), 16–22.
6. [6] van Dam, RM, Li, T, Spiegelman, D, Franco, OH, Hu, FB, Combined impact of lifestyle factors on mortality: prospective cohort study in US women. BMJ, 337, 2008.
7. [7] Åkesson, A, Larsson, SC, Discacciati, A, Wolk, A, Low-risk diet and lifestyle habits in the primary prevention of myocardial infarction in men: a population-based prospective cohort study. J Am Coll Cardiol 64 (2014), 1299–1306.
8. [8] Reedy, J, Krebs-Smith, SM, Miller, PE, Liese, AD, Kahle, LL, Park, Y, et al. Higher diet quality is associated with decreased risk of all-cause, cardiovascular disease, and cancer mortality among older adults. JN 144 (2014), 881–889.
9. [9] Berthold, HK, Rizzo, M, Spenrath, N, Montalto, G, Krone, W, Gouni-Berthold, I, Effects of lipid-lowering drugs on high-density lipoprotein subclasses in healthy men—a randomized trial. PLoS One, 9, 2014, e91565.
10. [10] Hegele, RA, Gidding, SS, Ginsberg, HN, McPherson, R, Raal, FJ, Rader, DJ, et al. Nonstatin low-density lipoprotein–lowering therapy and cardiovascular risk reduction—statement from ATVB council. Arterioscler Thromb Vasc Biol 35 (2015), 2269–2280.
11. [11] Krauss, RM, All low-density lipoprotein particles are not created equal. Arterioscler Thromb Vasc Biol 34 (2014), 959–961.
12. [12] Davidson, MH, Ballantyne, CM, Jacobson, TA, Bittner, VA, Braun, LT, Brown, AS, et al. Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists. J Clin Lipidol 5 (2011), 338–367.
13. [13] Austin, MA, Breslow, JL, Hennekens, CH, Buring, JE, Willett, WC, Krauss, RM, Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260 (1988), 1917–1921.
14. [14] Hulthe, J, Bokemark, L, Wikstrand, J, Fagerberg, B, The metabolic syndrome, LDL particle size, and atherosclerosis: the atherosclerosis and insulin resistance (AIR) study. Arterioscler Thromb Vasc Biol 20 (2000), 2140–2147.
15. [15] El Harchaoui, K, Arsenault, BJ, Franssen, R, Després, J-P, Hovingh, GK, Stroes, ES, et al. High-density lipoprotein particle size and concentration and coronary risk. Ann Intern Med 150 (2009), 84–93.
16. [16] Freedman, DS, Otvos, JD, Jeyarajah, EJ, Barboriak, JJ, Anderson, AJ, Walker, JA, Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler Thromb Vasc Biol 18 (1998), 1046–1053.
17. [17] Briel, M, Ferreira-Gonzalez, I, You, JJ, Karanicolas, PJ, Akl, EA, Wu, P, et al. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis. BMJ, 338, 2009, b92.
18. [18] Otvos, JD, Collins, D, Freedman, DS, Shalaurova, I, Schaefer, EJ, McNamara, JR, et al. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the veterans affairs high-density lipoprotein intervention trial. Circulation 113 (2006), 1556–1563.
19. [19] He, K, Song, Y, Daviglus, ML, Liu, K, Van Horn, L, Dyer, AR, et al. Accumulated evidence on fish consumption and coronary heart disease mortality. Circulation 109 (2004), 2705–2711.
20. [20] Mozaffarian, D, Lemaitre, RN, Kuller, LH, Burke, GL, Tracy, RP, Siscovick, DS, et al. Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the cardiovascular health study. Circulation 107 (2003), 1372–1377.
21. [21] Kris-Etherton, PM, Harris, WS, Appel, LJ, Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol 23 (2003), e20–e30.
22. [22] Harris, WS, Miller, M, Tighe, AP, Davidson, MH, Schaefer, EJ, Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis 197 (2008), 12–24.
23. [23] Kris-Etherton, PM, Harris, WS, Appel, LJ, Committee ftN, Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106 (2002), 2747–2757.
24. [24] Erkkilä, AT, Schwab, US, Lehto, S, de Mello, VD, Kangas, AJ, Soininen, P, et al. Effect of fatty and lean fish intake on lipoprotein subclasses in subjects with coronary heart disease: a controlled trial. J Clin Lipidol 8 (2014), 126–133.
25. [25] Lankinen, M, Kolehmainen, M, Jääskeläinen, T, Paananen, J, Joukamo, L, Kangas, AJ, et al. Effects of whole grain, fish and bilberries on serum metabolic profile and lipid transfer protein activities: a randomized trial (Sysdimet). PLoS One, 9, 2014, e90352.
26. [26] Kelley, DS, Siegel, D, Vemuri, M, Mackey, BE, Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men. AJCN 86 (2007), 324–333.
27. [27] Neff, LM, Culiner, J, Cunningham-Rundles, S, Seidman, C, Meehan, D, Maturi, J, Algal docosahexaenoic acid affects plasma lipoprotein particle size distribution in overweight and obese adults. JN 141 (2011), 207–213.
28. [28] Raatz, SK, Rosenberger, TA, Johnson, LK, Wolters, WW, Burr, GS, Picklo, MJ Sr., Dose-dependent consumption of farmed Atlantic Salmon (Salmo salar) increases plasma phospholipid n-3 fatty acids differentially. J Acad Nutr Diet 113 (2013), 282–287.
29. [29] Raatz, SK, Golovko, MY, Brose, SA, Rosenberger, TA, Burr, GS, Wolters, WR, et al. Baking reduces prostaglandin, resolvin, and hydroxy-fatty acid content of farm-raised Atlantic salmon (Salmo salar). J Ag Food Chem 59 (2011), 11278–11286.
30. [30] Folch, J, Lees, M, Sloane-Stanley, G, A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226 (1957), 497–509.
31. [31] Friedewald, WT, Levy, RI, Fredrickson, DS, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972), 499–502.
32. [32] Arterburn, LM, Hall, EB, Oken, H, Distribution, interconversion, and dose response of n-3 fatty acids in humans. AJCN 83 (2006), 1467S–1476S.
33. [33] Conquer, JA, Holub, BJ, Dietary docosahexaenoic acid as a source of eicosapentaenoic acid in vegetarians and omnivores. Lipids 32 (1997), 341–345.
34. [34] Vidgren, HM, Agren, JJ, Schwab, U, Rissanen, T, Hanninen, O, Uusitupa, MI, Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men. Lipids 32 (1997), 697–705.
35. [35] Bays, HE, Braeckman, RA, Ballantyne, CM, Kastelein, JJ, Otvos, JD, Stirtan, WG, et al. Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study). J Clin Lipidol 6 (2012), 565–572.
36. [36] Annuzzi, G, Rivellese, AA, Wang, H, Patti, L, Vaccaro, O, Riccardi, G, et al. Lipoprotein subfractions and dietary intake of n − 3 fatty acid: the genetics of coronary artery disease in Alaska natives study. AJCN 95 (2012), 1315–1322.
37. [37] Satoh, N, Shimatsu, A, Kotani, K, Sakane, N, Yamada, K, Suganami, T, et al. Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndrome. Diabetes Care 30 (2007), 144–146.
38. [38] Jensen, I-J, Walquist, M, Liaset, B, Elvevoll, EO, Eilertsen, K-E, Dietary intake of cod and scallop reduces atherosclerotic burden in female apolipoprotein E-deficient mice fed a western-type high fat diet for 13 weeks. Nutr Metab, 13, 2016, 1.
39. [39] Aadland, EK, Lavigne, C, Graff, IE, Eng, Ø, Paquette, M, Holthe, A, et al. Lean-seafood intake reduces cardiovascular lipid risk factors in healthy subjects: results from a randomized controlled trial with a crossover design. AJCN 102 (2015), 582–592.
40. [40] Agren, J, Hänninen, O, Julkunen, A, Fogelholm, L, Vidgren, H, Schwab, U, et al. Fish diet, fish oil and docosahexaenoic acid rich oil lower fasting and postprandial plasma lipid levels. EJCN 50 (1996), 765–771.
41. [41] Lupattelli, G, Lombardini, R, Schillaci, G, Ciuffetti, G, Marchesi, S, Siepi, D, et al. Flow-mediated vasoactivity and circulating adhesion molecules in hypertriglyceridemia: association with small, dense LDL cholesterol particles. Am Heart J 140 (2000), 521–526.
42. [42] Vakkilainen, J, Mäkimattila, S, Seppälä-Lindroos, A, Vehkavaara, S, Lahdenperä, S, Groop, P-H, et al. Endothelial dysfunction in men with small LDL particles. Circulation 102 (2000), 716–721.
43. [43] Williams, PT, Superko, HR, Haskell, WL, Alderman, EL, Blanche, PJ, Holl, LG, et al. Smallest LDL particles are most strongly related to coronary disease progression in men. Arterioscler Thromb Vasc Biol 23 (2003), 314–321.
44. [44] Beauchesne-Rondeau, É, Gascon, A, Bergeron, J, Jacques, H, Plasma lipids and lipoproteins in hypercholesterolemic men fed a lipid-lowering diet containing lean beef, lean fish, or poultry. AJCN 77 (2003), 587–593.
45. [45] Lacaille, B, Julien, P, Deshaies, Y, Lavigne, C, Brun, L-D, Jacques, H, Responses of plasma lipoproteins and sex hormones to the consumption of lean fish incorporated in a prudent-type diet in normolipidemic men. J Am Coll Nutr 19 (2000), 745–753.
46. [46] Bantle, JP, Raatz, SK, Thomas, W, Georgopoulos, A, Effects of dietary fructose on plasma lipids in healthy subjects. AJCN 72 (2000), 1128–1134.
47. [47] Heiss, G, Tamir, I, Davis, CE, Tyroler, HA, Rifkind, BM, Schonfeld, G, et al. Lipoproteins: cholesterol distributions in selected north American populations: the lipid research clinics program prevalence study. Circulation 61 (1980), 302–315.